open access

Vol 14, No 1 (2019)
Case Reports
Published online: 2019-04-10
Get Citation

Asymptomatic variant angina as the cause of sudden cardiac arrest

Marek Elżbieciak, Katarzyna Mizia-Stec
DOI: 10.5603/FC.2019.0010
·
Folia Cardiologica 2019;14(1):67-70.

open access

Vol 14, No 1 (2019)
Case Reports
Published online: 2019-04-10

Abstract

Vasospastic angina is a form of myocardial ischaemia caused by coronary artery spasm, with normal or almost normal angiography. Spasm of the coronary artery can lead to myocardial infarction, ventricular fibrillation, and sudden cardiac death. This article presents the history of a 47 year-old female who suffered cardiac arrest in the course of right coronary artery spasm. We consider the diagnostic difficulties and decisions regarding further treatment. 

Abstract

Vasospastic angina is a form of myocardial ischaemia caused by coronary artery spasm, with normal or almost normal angiography. Spasm of the coronary artery can lead to myocardial infarction, ventricular fibrillation, and sudden cardiac death. This article presents the history of a 47 year-old female who suffered cardiac arrest in the course of right coronary artery spasm. We consider the diagnostic difficulties and decisions regarding further treatment. 

Get Citation

Keywords

variant angina; cardiac arrest; ventricular fibrillation

About this article
Title

Asymptomatic variant angina as the cause of sudden cardiac arrest

Journal

Folia Cardiologica

Issue

Vol 14, No 1 (2019)

Pages

67-70

Published online

2019-04-10

DOI

10.5603/FC.2019.0010

Bibliographic record

Folia Cardiologica 2019;14(1):67-70.

Keywords

variant angina
cardiac arrest
ventricular fibrillation

Authors

Marek Elżbieciak
Katarzyna Mizia-Stec

References (8)
  1. Teragawa H, Kato M, Yamagata T, et al. The preventive effect of magnesium on coronary spasm in patients with vasospastic angina. Chest. 2000; 118(6): 1690–1695.
  2. Yasue H, Mizuno Y, Harada E, et al. SCAST (Statin and Coronary Artery Spasm Trial) Investigators. Effects of a 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor, fluvastatin, on coronary spasm after withdrawal of calcium-channel blockers. J Am Coll Cardiol. 2008; 51(18): 1742–1748.
  3. Sueda S, Suzuki J, Watanabe K, et al. Comparative results of coronary intervention in patients with variant angina versus those with non-variant angina. Jpn Heart J. 2001; 42(6): 657–667.
  4. Ono T, Ohashi T, Asakura T, et al. Internal mammary revascularization in patients with variant angina and normal coronary arteries. Interact Cardiovasc Thorac Surg. 2005; 4(5): 426–428.
  5. Takagi Y, Yasuda S, Tsunoda R, et al. Japanese Coronary Spasm Association. Clinical characteristics and long-term prognosis of vasospastic angina patients who survived out-of-hospital cardiac arrest: multicenter registry study of the Japanese Coronary Spasm Association. Circ Arrhythm Electrophysiol. 2011; 4(3): 295–302.
  6. Takagi Y, Yasuda S, Takahashi J, et al. Japanese Coronary Spasm Association. Clinical implications of provocation tests for coronary artery spasm: safety, arrhythmic complications, and prognostic impact: multicentre registry study of the Japanese Coronary Spasm Association. Eur Heart J. 2013; 34(4): 258–267.
  7. Takagi Y, Yasuda S, Tsunoda R, et al. Japanese Coronary Spasm Association. Clinical characteristics and long-term prognosis of vasospastic angina patients who survived out-of-hospital cardiac arrest: multicenter registry study of the Japanese Coronary Spasm Association. Circ Arrhythm Electrophysiol. 2011; 4(3): 295–302.
  8. Eschalier R, Souteyrand G, Jean F, et al. Should an implanted defibrillator be considered in patients with vasospastic angina? Arch Cardiovasc Dis. 2014; 107(1): 42–47.

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

 

Wydawcą serwisu jest  "Via Medica sp. z o.o." sp.k., ul. Świętokrzyska 73, 80–180 Gdańsk

tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail:  viamedica@viamedica.pl